GlassScriptPhysician profile
Susan P Demarest
NPI 1558680504
$5,477.00
in general payments reported to CMS, 2019-2025
32 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $220 · 2021: $449 · 2022: $843 · 2023: $1,080 · 2024: $606 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,209 · Gift: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,209.36 |
| Gift | $118.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $837.92 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $704.41 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Medtronic, INC. | $522.45 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Amgen INC. | $422.95 | 2019-2025 | Evenity, Tepezza, Repatha |
| Medtronic Minimed, INC. | $344.41 | 2019-2020 | |
| Insulet Corporation | $301.87 | 2022-2024 | Omnipod |
| Mannkind Corporation | $265.12 | 2023-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.78 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $216.92 | 2019-2025 | |
| Sequel Med Tech, LLC | $213.73 | 2025 | Twiist |
| Abbott Laboratories | $210.59 | 2022-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $198.48 | 2021-2025 | Dexcom G6 Transmitter |
| Tolmar, INC. | $132.10 | 2024-2025 | Jatenzo |
| Tandem Diabetes Care, INC. | $122.15 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $82.55 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $79.92 | 2023-2025 | Synthroid |
| Antares Pharma, INC. | $76.41 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Recordati_rare_diseases_inc. | $64.54 | 2024-2025 | Signifor Lar, Isturisa |
| Ascendis Pharma Endocrinology INC | $63.71 | 2025 | Yorvipath |
| Radius Health, INC. | $62.35 | 2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $50.79 | 2022-2025 | |
| Halozyme INC | $44.01 | 2023 | |
| Madrigal Pharmaceuticals | $34.68 | 2025 | Rezdiffra |
| Neurocrine Biosciences, INC. | $30.94 | 2025 | |
| Alnylam Pharmaceuticals INC. | $27.86 | 2025 | Givlaari |
| Amneal Pharmaceuticals LLC | $24.50 | 2023 | Unithroid |
| Merck Sharp & Dohme LLC | $22.82 | 2023 | Steglatro |
| Rhythm Pharmaceuticals, INC. | $21.89 | 2023 | Imcivree |
| Janssen Pharmaceuticals, INC | $20.11 | 2019 | |
| Ibsa Pharma INC. | $19.76 | 2024 | Licart, Tirosint |
| Rgh Enterprises LLC | $18.76 | 2024 | |
| Corcept Therapeutics | $16.52 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Demarest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.